Mutation-Driven Immune Microenvironments in Non-Small Cell Lung Cancer: Unrevealing Patterns through Cluster Analysis-Reference-Cited by-同舟云学术

Mutation-Driven Immune Microenvironments in Non-Small Cell Lung Cancer: Unrevealing Patterns through Cluster Analysis

Published:2024 Issue: Volume:65 Page:
ISSN:0513-5796
Container-title:Yonsei Medical Journal
language:en
Short-container-title:Yonsei Med J

Author:

Kim Youngtaek¹^ORCID,Hwang Joon Yeon¹^ORCID,Na Kwangmin¹^ORCID,Kim Dong Kwon²³^ORCID,Lee Seul²³^ORCID,Kang Seong-san⁴^ORCID,Baek Sujeong¹^ORCID,Yang Seung Min¹^ORCID,Kim Mi Hyun¹^ORCID,Han Heekyung¹^ORCID,Jeong Seong Su¹^ORCID,Lee Chai Young¹^ORCID,Han Yu Jin¹^ORCID,Sohn Jie-Ohn⁵^ORCID,Ye Sang-Kyu⁵⁶^ORCID,Pyo Kyoung-Ho²⁷⁸^ORCID

Affiliation:

1. Department of Research Support, Yonsei Biomedical Research Institute, Yonsei University College of Medicine, Seoul, Korea.

2. Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.

3. Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.

4. JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi, Korea.

5. Wide River Institute of Immunology, Seoul National University, Hongcheon, Korea.

6. Department of Pharmacology and Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.

7. Yonsei New Il Han Institute for Integrative Lung Cancer Research, Yonsei University College of Medicine, Seoul, Korea.

8. Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

Funder

National Research Foundation of Korea

Publisher

XMLink

Link

https://eymj.org/pdf/10.3349/ymj.2024.0062

Reference27 articles.

1. The global burden of lung cancer: current status and future trends

2. Review: Treating advanced non-small cell lung cancer in the elderly

3. Immunotherapy resistance in non-small-cell lung cancer: From mechanism to clinical strategies

4. Efficacy and safety analysis of immune checkpoint inhibitor rechallenge therapy in locally advanced and advanced non-small cell lung cancer: a retrospective study